Integra LifeSciences Holdings Corporation (FRA:IL3)
11.60
+0.10 (0.87%)
At close: Dec 5, 2025
FRA:IL3 Revenue
Integra LifeSciences Holdings had revenue of $402.06M USD in the quarter ending September 30, 2025, with 5.57% growth. This brings the company's revenue in the last twelve months to $1.64B, up 4.99% year-over-year. In the year 2024, Integra LifeSciences Holdings had annual revenue of $1.61B with 4.47% growth.
Revenue (ttm)
$1.64B
Revenue Growth
+4.99%
P/S Ratio
0.63
Revenue / Employee
$373.74K
Employees
4,396
Market Cap
886.50M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.61B | 68.95M | 4.47% |
| Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
| Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
| Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
| Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Integra LifeSciences Holdings News
- 2 days ago - Integra LifeSciences Holdings Corporation (IART) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 days ago - Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference - GlobeNewsWire
- 11 days ago - Integra LifeSciences (IART) Welcomes CMS Inclusion of Key Products in 2026 Rules - GuruFocus
- 11 days ago - Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - GlobeNewsWire
- 24 days ago - Integra LifeSciences Receives FDA Clearance For Cardiac Use Of CUSA Clarity System - Nasdaq
- 24 days ago - Integra LifeSciences (IART) Gains FDA Clearance for Cardiac Surgery Device - GuruFocus
- 24 days ago - Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries - Wallstreet:Online
- 24 days ago - Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries - GlobeNewsWire